Characterization of ex vivo expanded tumor infiltrating lymphocytes from patients with malignant melanoma for clinical application.
about
Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients.The microenvironment of human neuroblastoma supports the activation of tumor-associated T lymphocytesAdoptive cellular therapy of cancer: exploring innate and adaptive cellular crosstalk to improve anti-tumor efficacy.The critical role of mast cell-derived hypoxia-inducible factor-1α in human and mice melanoma growth.Adoptive Cellular Therapy (ACT) for Cancer Treatment.Characterization and comparison of 'standard' and 'young' tumour-infiltrating lymphocytes for adoptive cell therapy at a Danish translational research institution.
P2860
Characterization of ex vivo expanded tumor infiltrating lymphocytes from patients with malignant melanoma for clinical application.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Characterization of ex vivo ex ...... noma for clinical application.
@en
Characterization of ex vivo ex ...... noma for clinical application.
@nl
type
label
Characterization of ex vivo ex ...... noma for clinical application.
@en
Characterization of ex vivo ex ...... noma for clinical application.
@nl
prefLabel
Characterization of ex vivo ex ...... noma for clinical application.
@en
Characterization of ex vivo ex ...... noma for clinical application.
@nl
P2860
P50
P356
P1476
Characterization of ex vivo ex ...... noma for clinical application.
@en
P2093
Niels Junker
P2860
P304
P356
10.1155/2011/574695
P577
2011-06-18T00:00:00Z